Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Meseguer J
- Parrilla JJ
- Lara C
- Grifol R
- Alcover I
- Sala M
Grupos
Abstract
Previous trials have shown little benefit for preventing preterm birth in twin pregnancies using 90-200 mg of daily vaginal natural progesterone. Higher doses have not been tested. Our aim was to determine the efficacy and safety of two different daily doses of vaginal natural progesterone (200 and 400 mg), compared with placebo, for preventing preterm birth in unselected twin pregnancies.
Datos de la publicación
- ISSN/ISSNe:
- 1470-0328, 1471-0528
- Tipo:
- Article
- Páginas:
- 50-57
- PubMed:
- 22882759
- Factor de Impacto:
- 2,199 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY WILEY
Citas Recibidas en Web of Science: 76
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
SERRA V,PERALES A,Meseguer J,Parrilla JJ,Lara C,BELLVER J,Grifol R,Alcover I,Sala M,MARTÍNEZ JC,PELLICER A. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. BJOG. 2013. 120. (1):p. 50-57. IF:3,862. (1).
Portal de investigación